Results 151 to 160 of about 176,987 (331)
ABSTRACT Aim Serum tumor markers are helpful for diagnosis, monitoring treatment outcomes, and prognosis. However, their clinical utility for esophageal squamous cell carcinoma (ESCC) and gastric cancer (GC) remains unclear. This study aimed to comprehensively evaluate recent studies on serum tumor markers in ESCC and GC.
Yasunori Matsumoto +2 more
wiley +1 more source
Esophageal Adenocarcinomas: A Need for Speed Driven by Immune Pathways That Have Druggable Targets
Rhonda F. Souza, MD
doaj +1 more source
Prediction of left anterior descending coronary artery disease by esophageal echocardiography.
Kazuhide Fukagawa
openalex +2 more sources
Esophageal endoscopic aspects after forceful dilation of the gastric cardia in patients with achalasia of Chagas’ disease [PDF]
V. Félix +3 more
openalex +1 more source
ABSTRACT Background Nivolumab‐including chemotherapy (nivo‐CTX) for stage IV gastric cancer (GC) may increase the chance of conversion surgery but risk of immune‐related adverse events (irAEs) during perioperative period remains unclear. Methods We examined irAEs in 36 patients with marginally resectable GC who received nivo‐CTX followed by surgery ...
Masashi Nishino +11 more
wiley +1 more source
We systematically reviewed conversion therapy for esophageal squamous cell carcinoma and propose a response‐based treatment strategy for cT4b and M1 disease. For cT4b, we emphasize definitive chemoradiotherapy with timed re‐evaluation and selective salvage or chemoselection to surgery; for M1, conversion is reserved for limited‐burden responders with ...
Eisuke Booka, Hiroya Takeuchi
wiley +1 more source
Exploring Esophageal Microbiomes in Esophageal Diseases: A Systematic Review. [PDF]
Park CH, Lee SK.
europepmc +1 more source
Successful treatment of esophageal Crohn's disease with infliximab [PDF]
D Fefferman
openalex +1 more source

